Skip to main content

Find Clinical Trials

Home
Conditions
Small Cell Lung Cancer

Clinical trial condition

Small Cell Lung Cancer

Explore clinical trials studying Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

242 public trials 55 recruiting studies

Refine in advanced search Browse all conditions

Small Cell Lung Cancer trial results

Not Yet Recruiting

A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors

NCT07173244

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer

NCT07110363

Conditions: Advanced Lung Cancer, Advanced Malignant Solid Tumor, Bronchial Neoplasms, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Prophylactic Proton Pump Inhibition for Esophageal Protection in Lung Radiation Therapy

NCT07076914

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: London Health Sciences Centre London, Ontario, Canada

View Trial Details

Not Yet Recruiting

A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Cancer

NCT07076095

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study on the First-line Treatment of Small Cell Lung Cancer With Adebrelimab and Vunakizumab and Chemotherapy

NCT07069270

Conditions: Adebrelimab, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Efficacy and Biomarkers of the Second-line Treatment of Adebelizumab Combined With Irinotecan Liposome in Advanced Small Cell Lung Cancer

NCT07004712

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Peking university cancer hospital Beijing, Haidian, China

View Trial Details

Not Yet Recruiting

Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction

NCT06951841

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: The First Affiliated Hospital of China Medical University Shenyang, Liaoning, China

View Trial Details

Not Yet Recruiting

A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors

NCT06724263

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +46 more
Locations: Shanghai East Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer

NCT06581380

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer

NCT06462105

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Not specified

View Trial Details